Update - reverse takeover of Cellulac plc

RNS Number : 7918T

Integumen PLC

06 July 2018

 

6 July 2018

Integumen plc  ("Integumen" or "the Company")

Update - reverse takeover of Cellulac plc

Further to the notifications of April 16 2018 and June 29 2018, the Company advises that the Company and Cellulac have agreed not to proceed with the reverse takeover. The Company remains in discussions with Cellulac's board to agree an alternative transaction ("Proposed Transaction") in which Integumen would acquire a minority stake in Cellulac. Further information on the Proposed Transaction will be announced when it is finalised, which is expected shortly.

The Company's shares will remain suspended from trading on AIM pending the publication of the Report & Accounts for year ended 31 December 2017. The Company currently expects to publish these accounts contemporaneously with the Proposed Transaction.

ENDS

Integumen plc	Tony Richardson, Chairman	+ 353 (0) 87 770 5506
SPARK Advisory Partners Limited (Nominated Adviser)	Neil Baldwin/Andrew Emmott	[phone]
Hybridan LLP  (Broker)	Claire Noyce	[phone]
Turner Pope Investments (TPI) Ltd (Broker)	Ben Turner/James Pope	[phone]
Cardew Group	Shan Shan Willenbrock Joe McGregor	[phone] Mail to [e-mail]

 

END

 

 

OUPDBGDRBBGBGIU